Diabetes
Showing NaN - NaN of 123
Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec/insulin aspart, insulin aspart, insulin detemir)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin degludec/insulin aspart
- +2 more
-
Phoenix, Arizona
- +72 more
Jun 3, 2019
Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin aspart, insulin degludec)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- Faster-acting insulin aspart
- +2 more
-
Phoenix, Arizona
- +154 more
May 22, 2019
Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (insulin degludec, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- insulin glargine
-
Birmingham, Alabama
- +165 more
Apr 30, 2019
Cardiovascular Disease, Hypertension, Diabetes Trial in Dallas (Lay Health Promoter (LHP) with maintenance)
Completed
- Cardiovascular Disease
- +3 more
- Lay Health Promoter (LHP) with maintenance
-
Dallas, TexasUT Southwestern Medical Center
Feb 8, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, Insulin aspart, Insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- Faster-acting insulin aspart
- +2 more
-
Glendale, Arizona
- +143 more
Jan 10, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, liraglutide, exenatide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/liraglutide
- +2 more
-
Birmingham, Alabama
- +108 more
Dec 7, 2018
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/liraglutide
- insulin glargine
-
Fresno, California
- +90 more
Dec 7, 2018
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin degludec)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/liraglutide
- insulin degludec
-
Huntsville, Alabama
- +85 more
Dec 7, 2018
Diabetes, Diabetes, Type 1 Trial in Poland, Puerto Rico, United States (insulin degludec, insulin glargine, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin degludec
- +2 more
-
Birmingham, Alabama
- +98 more
Dec 7, 2018
Schizophrenia, Schizoaffective Disorder, Diabetes Trial in Dallas (Pramlintide, Placebo)
Completed
- Schizophrenia
- +3 more
- Pramlintide
- Placebo
-
Dallas, TexasThe University of Texas Southwestern Medical Center
Nov 14, 2018
Insulin Resistance, Hypertriglyceridemia, Diabetes Trial in Dallas (low-fat diet ( Still recruiting ), Diet)
Completed
- Insulin Resistance
- +3 more
- low-fat diet ( Still recruiting )
- Diet
-
Dallas, TexasUT Southwestern Medical Center
Oct 11, 2018
Diabetes, Diabetes, Type 2 Trial in United States (rosiglitazone, inhaled human insulin, metformin)
Terminated
- Diabetes
- Diabetes Mellitus, Type 2
- rosiglitazone
- +3 more
-
Hueytown, Alabama
- +102 more
Sep 3, 2018
Diabetes, Diabetes, Type 2 Trial in United States (pioglitazone, inhaled human insulin)
Terminated
- Diabetes
- Diabetes Mellitus, Type 2
- pioglitazone
- inhaled human insulin
-
Ozark, Alabama
- +109 more
Sep 3, 2018
Diabetes, Diabetes, Type 1 Trial in Canada, United States (inhaled human insulin, insulin detemir, insulin aspart)
Terminated
- Diabetes
- Diabetes Mellitus, Type 1
- inhaled human insulin
- +2 more
-
Birmingham, Alabama
- +95 more
Sep 3, 2018
Osteomyelitis: Procalcitonin to Diagnose and Monitor
Completed
- Diabetes
- +2 more
- 1 cohort, standard care, observational
-
Dallas, TexasUT Southwestern Medical Center
Jun 6, 2018
Diabetes, Prediabetes Trial in Dallas (Clinical Decision Support)
Completed
- Diabetes
- Prediabetes
- Clinical Decision Support
-
Dallas, TexasUT Southwestern Medical Center
Apr 16, 2018
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/insulin aspart
-
Goodyear, Arizona
- +44 more
Mar 6, 2018
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/insulin aspart, insulin degludec, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/insulin aspart
- +2 more
-
Greenbrae, California
- +50 more
Mar 6, 2018
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin degludec, liraglutide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/liraglutide
- +2 more
-
Birmingham, Alabama
- +301 more
Feb 16, 2018
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/liraglutide
- placebo
-
Anaheim, California
- +86 more
Sep 26, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, , liraglutide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- +2 more
-
Anaheim, California
- +131 more
Aug 25, 2017
Painful Diabetic Neuropathy, Diabetes Trial in United States (clonidine HCl topical gel, 0.1%)
Completed
- Painful Diabetic Neuropathy
- Diabetes
- clonidine hydrochloride topical gel, 0.1%
-
Phoenix, Arizona
- +19 more
Aug 23, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin detemir, Dietary regimen)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- Insulin detemir
- Dietary regimen
-
Birmingham, Alabama
- +111 more
Mar 28, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin Degludec, Insulin Glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- Insulin Degludec
- Insulin Glargine
-
Anaheim, California
- +80 more
Mar 9, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- +2 more
-
Alexander City, Alabama
- +135 more
Mar 8, 2017